The EIB and Utrecht-based AM-Pharma have signed a €24 million financing agreement. The funds will be used to accelerate the development of the clinical stage biopharmaceutical company’s recombinant alkaline phosphatase enzyme, which is used to treat acute kidney injury (AKI). The...
The 2025 edition of TXF’s annual Commodity Finance Research Report is now available. It reflects the views of a market that has been bruised by disruptions to trade: cautious,...
The main themes - including decarbonisation and political volatility - have been echoed in TXF’s earlier events. But the sense of urgency about transformations to economies...
TXF spoke with PuiYin Tham, vice president of business development at Marubeni to outline the benefits of taking the ECA funding route and how the Japanese developer’s deal pipeline is shaping up in the APAC region.
The 2025 edition of TXF’s annual Commodity Finance Research Report is now available. It reflects the views of a market that has been bruised by disruptions to trade: cautious, uncertain, yet optimistic about the resilience of the industry’s key pillars.
The main themes - including decarbonisation and political volatility - have been echoed in TXF’s earlier events. But the sense of urgency about transformations to economies and workforces is clear - and ECAs are starting to respond.
Connecting the Middle East and Africa. Step into the vibrant world of trade, agency and project finance at Exile’s (TXF, Proximo and Uxolo) MEA 2026.
View more
Unveil Amsterdam's allure! Elevate your pipeline with top dealmakers. An Industry Awards dinner adds glamour to this unmissable adventure.
View more